References

  1. World Health Organization. Cardiovascular diseases (CVDs). Fact sheet. Reviewed September 2016. Accessed on 28/10/2016.

  2. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries. Curr Probl Cardiol. 2010; 35(2): 72-115. PubMed | Google Scholar

  3. Tóth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006. J Clin Lipidol. 2012; 6(4): 325-30. PubMed | Google Scholar

  4. Talita Gabriela de Limas Gustavo de Araujo Pinto Liz Miriane Marcato Daniel Reszel Coelho. Analysis of the prevalence of dyslipidemia in individuals with HIV and its association with antiretroviral therapy. Rev Soc Bras Med Trop. Oct 2014; 47(5): ISSN 0037-8682. Google Scholar

  5. Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Research and Therapy. 2012; 9(1): 31. PubMed | Google Scholar

  6. Oguejiofor OC, Onwukwe CH, Odenigbo CU. Dyslipidemia in Nigeria: prevalence and pattern. Ann Afr Med. 2012; 11(4): 197-202. PubMed | Google Scholar

  7. Raal FJ, Med M. Pathogenesis and Management of the Dyslipidemia of the Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 2009; 7(2): 83-88. PubMed | Google Scholar

  8. Report of WHO Scientific Group. Cardiovascular disease risk factors: new areas for research. WHO Technical Report Series No 841. Geneva: WHO; 1994. Accessed on 28/10/2016.

  9. European Atherosclerosis Society. International Task Force for prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr Metab Cardiovascular Dis. 1992; 2: 113-56. Google Scholar

  10. Ernest Ndukaife Anyabolu. Low Density Lipoprotein Cholesterol in a General Out-patient Population in a Tertiary Hospital in Southeast Nigeria: associations and implications. Clinical Medicine and Diagnostics. 2017; 7(1): 8-17. Google Scholar

  11. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004 Jul 13; 110(2): 227-39. PubMed | Google Scholar

  12. NutritionMD.org. Hyperlipidemia: References 2016. Accessed 0n 29/10/2016.

  13. Federal Republic of Nigeria. Global AIDS response and progress report. 2012. Google Scholar

  14. Anyabolu EN, Chukwuonye II, Arodiwe E, Ijoma CK, Ulasi I. Prevalence and predictors of chronic kidney disease in newly diagnosed human immunodeficiency virus patients in Owerri, Nigeria. Indian J Nephrol. 2016; 26(1): 10-5. PubMed | Google Scholar

  15. Anyabolu EN, Chukwuonye II, Mabayoje M, Ejike A, Ijoma CK, Oviasu E, Kadiri S. Comparison of Spot Urine Protein/Creatinine Ratio, Spot Urine Protein/Osmolality Ratio with Measured 24-Hour Urine Protein in HIV Subjects in Nigeria. J AIDS Clin Res. 2015; 6: 445. Google Scholar

  16. Anyabolu EN. Body Mass Index and Associated Factors of Obesity and Underweight in a general out-patient population in a tertiary hospital in Nigeria. American Journal of Internal Medicine. 2016; 4(5): 85-92. Google Scholar

  17. WHO (1995). Physical Status: The Use and Interpretation of Anthropometry. Technical Report Series 854, 1-1-9950. World Health Organization, Geneva. Accessed on 29/10/2016.

  18. Yeh HC, Lin YS, Kuo CC, Weidemann D, Weaver V, Fadrowski J et al. Urine osmolality in the US population: implications for environmental biomonitoring. Environ Res. 2015 Jan; 136: 482-90. PubMed | Google Scholar

  19. Anyabolu EN, Chukwuonye II. Urine Osmolality in Adults Attending a General out-Patient Clinic. Clinical Implications, American Journal of Medicine and Medical Sciences. 2016; 6(5): 145-151. Google Scholar

  20. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity VMNIS | Vitamin and Mineral Nutrition Information System WHO/NMH/NHD/MNM/11.1. Accessed on 29/10/2016.

  21. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486. Google Scholar

  22. Manuthu EM, Joshi MD, Lule GN, Karari E. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East Afr Med J. 2008 Jan; 85(1): 10-7. PubMed | Google Scholar

  23. Armstrong C, Liu E, Grinspoon S, Okuma J, Spiegelman et al. Claudia Hawkins: dyslipidemia in an HIV-positive, antiretroviral treatment-naïve population in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2011 Jun 1; 57(2): 141-145. Google Scholar

  24. Moore F, Howard AA, Lo Y, Arnsten JH, Santoro N, Schoenbaum EE. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med. 2006 Oct; 7(7): 421-30. Google Scholar

  25. Zaribaf F, Entezari MH, Hassanzadeh A, Mirzaian S. Association between dietary iron, iron stores and serum lipid profile in reproductive age women. J Educ Health Promot. 2014; 3: 15. PubMed | Google Scholar

  26. Tsimihodimos V, Mitrogianni Z, Elisaf M. Dyslipidemia Associated with Chronic Kidney Disease. Open Cardiovasc Med J. 2011; 5: 41-48. PubMed | Google Scholar

  27. Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int. July 2016; 90(1): 41-52. PubMed | Google Scholar

  28. Adu EM. Serum lipid profile abnormalities among patients with nephrotic. Int J Med Biomed Res. 2013; 2(1): 13-17. Google Scholar

  29. Anyabolu EN. Urine creatinine in treatment-naïve HIV subjects in eastern Nigeria. The Pan African Medical Journal. 2016; 25: 139. PubMed | Google Scholar

  30. Waldo HB, Mariana de Paz S, Matilde N, Marisa L, Aeiel G. Impaired Urine Dilution Capability in HIV Stable Patients. Int J Nephrol. 2014; 2014: 381985. Google Scholar